Smear positive pulmonary tuberculosis and associated risk factors among tuberculosis suspects attending spiritual holy water sites in Northwest Ethiopia.
Derseh D, Moges F, Tessema B.
BMC Infect Dis. 2017 Jan 26;17(1):100. doi: 10.1186/s12879-017-2211-5.
PMID:28125981
Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania.
de Jonghe E, Murray CJ, Chum HJ, Nyangulu DS, Salomao A, Styblo K.
Int J Health Plann Manage. 1994 Apr-Jun;9(2):151-81. doi: 10.1002/hpm.4740090204.
PMID:10172113
Sputum smear conversion and associated factors among smear-positive pulmonary tuberculosis patients in East Gojjam Zone, Northwest Ethiopia: a longitudinal study.
Prevalence and associated factors of delayed sputum smear conversion in patients treated for smear positive pulmonary tuberculosis: A retrospective follow up study in Sabah, Malaysia.
Khor LA, A Wahid UNI, Ling LL, Liansim SMS, Oon J, Balakrishnan MN, Ng WL, Cheong AT.
PLoS One. 2023 Mar 6;18(3):e0282733. doi: 10.1371/journal.pone.0282733. eCollection 2023.
PMID:36877714
Changes of CRP serum levels in pulmonary TB patients with AFB smear-positive sputum before and two months after receiving anti-tuberculosis drug treatment.
Soedarsono S, Subiantoro MC.
Indian J Tuberc. 2019 Jan;66(1):134-138. doi: 10.1016/j.ijtb.2018.07.007. Epub 2018 Oct 12.